Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoChange DetectedThe webpage has been updated to reflect new results and data regarding the EQ001 study, including new reporting dates and metrics related to treatment emergent adverse events, while older data from 2022 has been removed.SummaryDifference5%
- Check27 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study information about a clinical trial for itolizumab (EQ001) in asthma, while retaining some key elements such as the study design and collaborators.SummaryDifference38%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check85 days agoChange DetectedThe page has been updated to indicate that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.